Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Sale |
2025-02-20 5:14 pm |
Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks |
13,871 | $1.6919 | $23,468 | 7,804,295 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-20 5:14 pm |
Neumora Therapeutics Inc. | NMRA | Milligan Michael Lee See Remarks |
1,978 | $1.6939 | $3,351 | 22,470 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-20 5:13 pm |
Neumora Therapeutics Inc. | NMRA | Aurora Daljit Singh Chief Strategy Officer |
8,565 | $1.6751 | $14,347 | 203,638 (Indirect Direct) |
View |
| 2025-02-18 Sale |
2025-02-20 5:12 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
5,614 | $1.6714 | $9,383 | 309,092 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-20 5:11 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
8,048 | $1.6746 | $13,477 | 215,917 (Indirect Direct) |
View |
| 2024-10-17 Sale |
2024-10-18 6:25 pm |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
21,788 | $17.03 | $370,962 | 205,321 (Direct) |
View |
| 2024-10-09 Sale |
2024-10-11 4:10 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
13,823 | $15.06 | $208,110 | 314,706 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:35 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
41,464 | $11.89 | $492,827 | 328,529 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 4:05 pm |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
32,948 | $11.43 | $376,665 | 369,993 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-27 5:58 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
15,693 | $11.39 | $178,806 | 223,965 (Indirect Direct) |
View |
| 2024-08-22 Sale |
2024-08-26 6:17 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
84,307 | $11.67 | $984,061 | 239,658 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-28 Option Award |
2025-05-30 6:31 pm |
N/A 2032-01-27 |
Neumora Therapeutics Inc. | NMRA | Milligan Michael Lee See Remarks |
593,550 | $0 | 593,550 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2033-12-11 |
Neumora Therapeutics Inc. | NMRA | Duncan Jason See Remarks |
900,000 | $0 | 900,000 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2031-04-23 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
221,959 | $0 | 221,959 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
155,026 | $0 | 155,026 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2031-09-20 |
Neumora Therapeutics Inc. | NMRA | Aurora Daljit Singh See Remarks |
1,819,497 | $0 | 1,819,497 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Piacquad David Director |
155,026 | $0 | 155,026 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2032-01-27 |
Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks |
3,795,413 | $0 | 3,795,413 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2031-04-23 |
Neumora Therapeutics Inc. | NMRA | Ho Maykin Director |
231,959 | $0 | 231,959 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Halawa Alaa Director |
155,026 | $0 | 155,026 (Direct) |
View |
| 2025-05-28 Option Award |
2025-05-30 6:25 pm |
N/A 2031-06-07 |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
4,734,428 | $0 | 4,734,428 (Direct) |
View |
| 2025-05-21 Gift |
2025-05-23 4:42 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
13,202 | $0 | 215,917 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | BERNS PAUL L See Remarks |
3,795,413 | $0 | 3,795,413 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2031-04-23 |
Neumora Therapeutics Inc. | NMRA | Ho Maykin Director |
151,959 | $0 | 151,959 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
602,934 | $0 | 602,934 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Aurora Daljit Singh See Remarks |
1,819,497 | $0 | 1,819,497 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2031-04-23 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
141,959 | $0 | 141,959 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Piacquad David Director |
75,026 | $0 | 75,026 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
75,026 | $0 | 75,026 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Milligan Michael Lee See Remarks |
593,550 | $0 | 593,550 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
4,734,428 | $0 | 4,734,428 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Duncan Jason See Remarks |
900,000 | $0 | 900,000 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2033-09-14 |
Neumora Therapeutics Inc. | NMRA | Halawa Alaa Director |
75,026 | $0 | 75,026 (Direct) |
View |
| 2024-12-27 Gift |
2024-12-27 5:01 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | BERNS PAUL L Director |
133,097 | $0 | 7,818,166 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A 2030-09-07 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
21,788 | $0 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
10,000 | $2.52 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
3,783 | $8.32 | 205,321 (Direct) |
View |
| 2024-10-17 Exercise |
2024-10-18 6:25 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
8,005 | $8.79 | 205,321 (Direct) |
View |
| 2024-09-12 Gift |
2024-09-13 5:22 pm |
N/A 2031-09-20 |
Neumora Therapeutics Inc. | NMRA | Aurora Daljit Singh Chief Strategy Officer |
606,970 | $0 | 836,700 (Direct) |
View |
| 2024-04-17 Gift |
2024-06-28 9:00 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
238,965 | $0 | 323,965 (Indirect) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:18 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Ho Maykin Director |
48,671 | $0 | 48,671 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:16 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Piacquad David Director |
48,671 | $0 | 48,671 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:14 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Halawa Alaa Director |
48,671 | $0 | 48,671 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:13 pm |
N/A 2034-06-12 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
48,671 | $0 | 48,671 (Direct) |
View |